Axsome Therapeutics (AXSM) · AXS-12
Later window · A neutral label from comparing the two stated windows. It says nothing about the program’s results.
Before
Stated timing: in January 2026
Axsome anticipates completing the NDA submission in January 2026.
EX-99.1 · filed · SEC filing
After
Stated timing: 1Q 2026
AXS-12 for narcolepsy, NDA submission (1Q 2026)
SEC original · filed · SEC filing
Data as of . Both sentences are quoted from the SEC filings linked above and matched to them.
Source: ORION, orionbiotechai.com/changes/AXSM-axs-12-2026-02-23, data as of Oct 13, 2026
https://www.orionbiotechai.com/changes/AXSM-axs-12-2026-02-23
Axsome Therapeutics (AXSM) pipeline and stated timing · Calendar · Companies A–Z